Keywords = Ribavirin
| Number of Articles: 33 | ||||
| 1 | Study of the effects of Sofosbuvir based treatments on liver stiffness in chronic Hepatitis C patients using transient Elastography | |||
| Articles in Press, Accepted Manuscript , Available Online from 07 November 2023 | ||||
| Osama Mohamed Basha; Mahmoud Al Gharieb Abd ELBari; Ahmed Awad Bessar; Amr Shaban Hanafy | ||||
| 2 | Potential antiviral activity of metformin against human Adenovirus-7 | |||
| Volume 5, Issue 2, May 2024, Page 567-576 | ||||
| Ibrahim Ashraf Abdelwahab; Gihan Adel ELBatouti | ||||
| 3 | The Histopathological Effect of Sofosbuvir as Compared to Sofosbuvir Combined with Ribavirin on Submandibular Salivary Glands of Adult Albino Rats (Histological and Immunofluorescent Study) | |||
| Volume 46, Issue 3, September 2023, Page 1262-1271 | ||||
| Alaa Ossama Shawkat; Zoba H Ali; maha bashir | ||||
| 4 | Serum markers in monitoring the outcome of Sofosbuvir-based treatments in HCV genotype 4 Egyptian patients | |||
| Volume 60, Issue 1, January 2022, Page 73-84 | ||||
| Hiam Salem; Nadia Y. S. Morcos; Wahid Doss; Mohamed Makhlouf; Kamal El Atrebi; Eman Saleh | ||||
| 5 | Association of ITPA Gene Expression and Hematological Abnormalities Induced by Dual therapy in HCV-infected Patients | |||
| Volume 11, Issue 1, September 2021, Page 56-66 | ||||
| Naglaa ELarabany; Nahed A. Omar; Mostafa M. Elshaer; Ahmed Abdelkhalek; Mai Alaa Eldin Ali Rashed | ||||
| 6 | Assessment of Patient Compliance during treatment of chronic hepatitis C infection using Sofosbuvir and Daclatasvir with or without Ribavirin. | |||
| Volume 5.2, Issue 2, March 2021, Page 32-39 | ||||
| Sarah Ali; Farag Mohamed; Maha R Habeeb | ||||
| 7 | Outcome of Decompensated Hepatitis C Virus Cirrhotic Patients Treated with Direct Acting Antiviral Drugs | |||
| Volume 27, Issue 1, January 2021, Page 70-80 | ||||
| Amir Ahmed; Sahar Gouda Zagloul; Hoda Abdel-aziz El-hady; Ahmed Fathy Gomaa | ||||
| 8 | Studying the Kynurenine, Some Hematological and Biochemical Changes on Egyptian Patients with Chronic Hepatitis C During and After Treatment with Sofosbuvir | |||
| Volume 5, Issue 7 part (1) - (2), October 2020, Page 291-301 | ||||
| N. H. Abdel_Hameid; L.Y. Mousa; E.M. Shaheen; F. S. Ibrahim | ||||
| 9 | Evaluation of the Role of the Silymarin in Modulating the Cytotoxicity of Sofosbuvir and Ribavirin as Antiviral Drugs in Mice Bone Marrow and Sperm | |||
| Volume 5, Issue 6 part (1), September 2020, Page 133-139 | ||||
| M.E. Zowail; N.A. El kamshishy; E.H. Khater | ||||
| 10 | Efficacy of Sofosbuvir-Daclatasvir in Treatment of Chronic Hepatitis C Virus Infection | |||
| Volume 5, Issue 6 part (2), September 2020, Page 241-251 | ||||
| Y.S. Younis; T.E. Elazab; E.M. Abd El-Fattah | ||||
| 11 | MOLECULAR MARKERS PREDICTING THE EFFICACY OF INTERFERON-BASED THERAPIES IN PATIENTS WITH CHRONIC HEPATITIS C | |||
| Volume 35, Issue 1, January and February 2020, Page 1-16 | ||||
| 12 | Retinal Changes In Patients with Hepatitis C Virus under treatment with interferon and ribavirin. | |||
| Volume 1, Issue 1, January 2020, Page 107-121 | ||||
| Mansour Hassan Ahmad Hassan; Mohamed Osman; Waleed El-Nabawy; Alzahraa Yasseen Sayed | ||||
| 13 | Evaluation of Sofosbuvir plus Ribavirinin Treatment of Cirrhotic Hepatitis C Patients: An Egyptian Study | |||
| Volume 28, Issue 1, January 2019, Page 15-22 | ||||
| Alaa Aboud; Mostafa S. ABDEL-MOTaleb; Ehab M. Fahmy | ||||
| 14 | Efficacy and Adverse Effects of Sofosbuvir plus Daclatasvir Therapy in Chronic HCV Patients in Sharkia Governorate, Egypt | |||
| Volume 8, Issue 4, December 2018, Page 174-181 | ||||
| Nahla E El-Gammal; Noha E Shahin; Abeer Hussein abdelkader | ||||
| 15 | Comparison between the effect of Two Regimens for Hepatitis C Treatment (Qurevo and Ribavirin) and (Sofosbuvir, Daclatsvir and Ribavirin) on Patients above and below the Age of 60 Years | |||
| Volume 72, Issue 10, July 2018, Page 5385-5390 | ||||
| Mahmoud Abd El Majeed Othman; Motaz Mohamed Saied Abd EL Mawjood; Mohamed Osama Aly Aly; Aya Ahmed Morsy El Ghamry | ||||
| 16 | EFFICACY OF SOFOSBUVIR, DACLAVIR AND RIBAVIRIN IN TREATMENT OF HCV INFECTION WITH DIFFERENT STAGES OF LIVER DISEASE | |||
| Volume 47, Issue 2, April 2018, Page 305-320 | ||||
| Magdy A. ELDahshan; Fathy E. Abdel Razik; Hala M Abdel-Mageed; Ayman R. Abd El-Kader; Tarek Refaat; Hassan Ahmed Hassan Ghareeb | ||||
| 17 | EFFECTS OF SOFOSBUVIR AND RIBAVIRIN ON SOME HAEMATOLOGICAL AND BIOCHEMICAL PARAMETERS IN NORMAL RATS | |||
| Volume 68, Issue 68, December 2017, Page 181-196 | ||||
| N. F. Elarabany; S. A. Eltamtame; K. A. Elbakry; G. A. Abdallah | ||||
| 18 | THE USE OF DACLATASVIR PLUS SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN IN TREATMENT-NAÏVE PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 4 INFECTION | |||
| Volume 68, Issue 68, December 2017, Page 239-254 | ||||
| N. Elarabany; Hend M. Solyman; Tarek A. Besheer; Gamal A. Abd-Allah | ||||
| 19 | Chronic Hepatitis C Treatment: A Systematic Review | |||
| Volume 67, Issue 1, April 2017, Page 305-313 | ||||
| Aishah Mohammed Alenezi; Abdulaziz Hassan Mohammed Al-Fakih; Sultan Mohammed Al-Afif; Abdulkarem Mohammed Al-Afif; Bashayer Abbas Habib | ||||
| 20 | IMPACT OF INSULIN RESISTANCE AND SERUM ZINC ON RESPONSE TO PEG-INTERFERON/RIBAVIRIN COMBINATION THERAPY IN NON-DIABETIC PATIENTS WITH CHRONIC HEPATITIS C | |||
| Volume 46, Issue 1, January 2017, Page 45-56 | ||||
| Adel Ahmed Soliman Al-Sahhar; Alsayed Almaghawry Alsayed; Hassan Abdel-Hafiez Rashed; Ali Ebraheim Ali Soliman; Mahmoud Bastawy Ismael; Mohammad Fawzy Abdel-Gaber | ||||
| 21 | Pegylated Interferon, Ribavirin, and Sofosbuvir Combination versus Pegylated Interferon, Ribavirin in the Management of Chronic Hepatitis C Egyptian Patients | |||
| Volume 1, Issue 1, January 2017, Page 25-33 | ||||
| Abdel-Hameed Ebid; Mohamed Mobarez; Mohamed Adel; Ramadan Ramadan | ||||
| 22 | Histological Study on the Effects of Sofosbuvir and/or Ribavirin on Normal Rats | |||
| Volume 6, Issue 2, December 2016, Page 144-149 | ||||
| Gamal A. Abdallah; Kadry A. Elbakry; Naglaa F. Elarabany; Seeg A. Altamtam | ||||
| 23 | Sofosbuvir plus Ribavirin for Treatment-Naïve Chronic HCV Genotype 4 Patients: Real-life Experience | |||
| Volume 2.1, Issue 1, November 2016, Page 1-8 | ||||
| Shiha G.; El-Basiouny M.; Soliman R.; Mikhail NNH. | ||||
| 24 | Impact Of An Eductional Program On: Knowledge And Practice Of Hepatitis C Infected Patients Treated By Pegylated Interferon And Ribavirin. | |||
| Volume 3, Issue 1, June 2016, Page 190-211 | ||||
| Shaimaa Abdo Rizq | ||||
| 25 | Dermatological Manifestations of Pegylated Interferon alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients | |||
| Volume 6, Issue 2, June 2016, Page 94-102 | ||||
| Mohamed H Khater; Fathia M Khattab; Mohamed M Refaey | ||||
| | ||||
View on SCiNiTO
